nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—PNP—osteoporosis	0.595	1	CbGaD
Cladribine—SLC22A1—Estropipate—osteoporosis	0.0712	0.378	CbGbCtD
Cladribine—SLC22A2—Estradiol—osteoporosis	0.034	0.181	CbGbCtD
Cladribine—SLC22A1—Estradiol—osteoporosis	0.0295	0.157	CbGbCtD
Cladribine—ABCG2—Conjugated Estrogens—osteoporosis	0.0286	0.152	CbGbCtD
Cladribine—ABCG2—Estradiol—osteoporosis	0.0251	0.133	CbGbCtD
Cladribine—POLE2—bone marrow—osteoporosis	0.00121	0.143	CbGeAlD
Cladribine—PNP—uterus—osteoporosis	0.000905	0.107	CbGeAlD
Cladribine—PNP—bone marrow—osteoporosis	0.000768	0.0906	CbGeAlD
Cladribine—RRM2B—bone marrow—osteoporosis	0.000713	0.0841	CbGeAlD
Cladribine—POLE3—bone marrow—osteoporosis	0.000674	0.0795	CbGeAlD
Cladribine—POLE—Fulvestrant—Estradiol—osteoporosis	0.00065	0.195	CbGdCrCtD
Cladribine—SLC28A3—bone marrow—osteoporosis	0.000631	0.0744	CbGeAlD
Cladribine—POLE—bone marrow—osteoporosis	0.000514	0.0607	CbGeAlD
Cladribine—RRM2—uterus—osteoporosis	0.000499	0.0589	CbGeAlD
Cladribine—POLA1—bone marrow—osteoporosis	0.000443	0.0523	CbGeAlD
Cladribine—RRM1—Fulvestrant—Estradiol—osteoporosis	0.000432	0.13	CbGdCrCtD
Cladribine—RRM2—bone marrow—osteoporosis	0.000423	0.0499	CbGeAlD
Cladribine—RRM1—uterus—osteoporosis	0.000414	0.0489	CbGeAlD
Cladribine—RRM1—bone marrow—osteoporosis	0.000352	0.0415	CbGeAlD
Cladribine—POLE2—Fulvestrant—Estradiol—osteoporosis	0.000341	0.103	CbGdCrCtD
Cladribine—DCK—uterus—osteoporosis	0.000322	0.038	CbGeAlD
Cladribine—DCK—bone marrow—osteoporosis	0.000273	0.0322	CbGeAlD
Cladribine—PNP—Fulvestrant—Estradiol—osteoporosis	0.000263	0.0792	CbGdCrCtD
Cladribine—PNP—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.000247	0.0742	CbGdCrCtD
Cladribine—PNP—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.000241	0.0724	CbGdCrCtD
Cladribine—ABCG2—uterus—osteoporosis	0.00018	0.0212	CbGeAlD
Cladribine—DCK—Fulvestrant—Estradiol—osteoporosis	0.000154	0.0462	CbGdCrCtD
Cladribine—ABCG2—bone marrow—osteoporosis	0.000152	0.018	CbGeAlD
Cladribine—POLA1—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000147	0.0441	CbGdCrCtD
Cladribine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.000144	0.0433	CbGdCrCtD
Cladribine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.000141	0.0423	CbGdCrCtD
Cladribine—POLA1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000117	0.0351	CbGdCrCtD
Cladribine—PNP—Danazol—Ethinyl Estradiol—osteoporosis	0.000115	0.0346	CbGdCrCtD
Cladribine—POLE2—Cell Cycle—PSMA5—osteoporosis	0.000108	0.00167	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000108	0.00166	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—TPI1—osteoporosis	0.000106	0.00164	CbGpPWpGaD
Cladribine—Urethral disorder—Estradiol—osteoporosis	0.000105	0.000755	CcSEcCtD
Cladribine—Rash—Etidronic acid—osteoporosis	0.000105	0.000754	CcSEcCtD
Cladribine—Dermatitis—Etidronic acid—osteoporosis	0.000105	0.000753	CcSEcCtD
Cladribine—Hyperhidrosis—Pamidronate—osteoporosis	0.000105	0.000751	CcSEcCtD
Cladribine—Hypersensitivity—Alendronate—osteoporosis	0.000105	0.000751	CcSEcCtD
Cladribine—Headache—Etidronic acid—osteoporosis	0.000104	0.000749	CcSEcCtD
Cladribine—POLE—Mitotic M-M/G1 phases—PSMA5—osteoporosis	0.000104	0.0016	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—PSMA2—osteoporosis	0.000104	0.0016	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000104	0.000745	CcSEcCtD
Cladribine—PNP—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000104	0.0311	CbGdCrCtD
Cladribine—POLE—G1 to S cell cycle control—MYC—osteoporosis	0.000104	0.0016	CbGpPWpGaD
Cladribine—Asthenia—Estropipate—osteoporosis	0.000104	0.000742	CcSEcCtD
Cladribine—Anorexia—Pamidronate—osteoporosis	0.000103	0.000741	CcSEcCtD
Cladribine—Chest pain—Zoledronate—osteoporosis	0.000103	0.00074	CcSEcCtD
Cladribine—Myalgia—Zoledronate—osteoporosis	0.000103	0.00074	CcSEcCtD
Cladribine—Arthralgia—Zoledronate—osteoporosis	0.000103	0.00074	CcSEcCtD
Cladribine—Insomnia—Risedronate—osteoporosis	0.000103	0.000739	CcSEcCtD
Cladribine—Anxiety—Zoledronate—osteoporosis	0.000103	0.000738	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000103	0.000735	CcSEcCtD
Cladribine—Paraesthesia—Risedronate—osteoporosis	0.000102	0.000734	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000102	0.00158	CbGpPWpGaD
Cladribine—Pruritus—Estropipate—osteoporosis	0.000102	0.000732	CcSEcCtD
Cladribine—Discomfort—Zoledronate—osteoporosis	0.000102	0.000732	CcSEcCtD
Cladribine—Asthenia—Alendronate—osteoporosis	0.000102	0.000731	CcSEcCtD
Cladribine—Hypersensitivity—Ibandronate—osteoporosis	0.000102	0.000731	CcSEcCtD
Cladribine—Cough—Conjugated Estrogens—osteoporosis	0.000102	0.000731	CcSEcCtD
Cladribine—RRM2—E2F transcription factor network—MYC—osteoporosis	0.000102	0.00157	CbGpPWpGaD
Cladribine—RRM1—Metabolism—FDPS—osteoporosis	0.000102	0.00157	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PKM—osteoporosis	0.000102	0.00157	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP27A1—osteoporosis	0.000102	0.00157	CbGpPWpGaD
Cladribine—DCK—Levorphanol—Estradiol—osteoporosis	0.000102	0.0306	CbGdCrCtD
Cladribine—Dyspnoea—Risedronate—osteoporosis	0.000102	0.000729	CcSEcCtD
Cladribine—Erythema multiforme—Estradiol—osteoporosis	0.000102	0.000728	CcSEcCtD
Cladribine—Hypotension—Pamidronate—osteoporosis	0.000101	0.000726	CcSEcCtD
Cladribine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000101	0.000724	CcSEcCtD
Cladribine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000101	0.000723	CcSEcCtD
Cladribine—Pruritus—Alendronate—osteoporosis	0.000101	0.000721	CcSEcCtD
Cladribine—Eye disorder—Estradiol—osteoporosis	0.0001	0.000719	CcSEcCtD
Cladribine—POLE2—S Phase—MYC—osteoporosis	0.0001	0.00154	CbGpPWpGaD
Cladribine—Constipation—Ethinyl Estradiol—osteoporosis	0.0001	0.000717	CcSEcCtD
Cladribine—Confusional state—Zoledronate—osteoporosis	9.98e-05	0.000716	CcSEcCtD
Cladribine—Hypersensitivity—Calcitriol—osteoporosis	9.98e-05	0.000715	CcSEcCtD
Cladribine—RRM2B—Metabolism—P4HB—osteoporosis	9.98e-05	0.00154	CbGpPWpGaD
Cladribine—Cardiac disorder—Estradiol—osteoporosis	9.97e-05	0.000715	CcSEcCtD
Cladribine—Arthralgia—Conjugated Estrogens—osteoporosis	9.95e-05	0.000713	CcSEcCtD
Cladribine—Chest pain—Conjugated Estrogens—osteoporosis	9.95e-05	0.000713	CcSEcCtD
Cladribine—Myalgia—Conjugated Estrogens—osteoporosis	9.95e-05	0.000713	CcSEcCtD
Cladribine—Asthenia—Ibandronate—osteoporosis	9.93e-05	0.000712	CcSEcCtD
Cladribine—Anxiety—Conjugated Estrogens—osteoporosis	9.91e-05	0.00071	CcSEcCtD
Cladribine—Nausea—Etidronic acid—osteoporosis	9.91e-05	0.00071	CcSEcCtD
Cladribine—Oedema—Zoledronate—osteoporosis	9.9e-05	0.00071	CcSEcCtD
Cladribine—PNP—Metabolism—ACP5—osteoporosis	9.9e-05	0.00153	CbGpPWpGaD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.88e-05	0.000708	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.88e-05	0.000708	CcSEcCtD
Cladribine—Diarrhoea—Estropipate—osteoporosis	9.87e-05	0.000708	CcSEcCtD
Cladribine—Gastrointestinal disorder—Risedronate—osteoporosis	9.84e-05	0.000706	CcSEcCtD
Cladribine—Infection—Zoledronate—osteoporosis	9.84e-05	0.000705	CcSEcCtD
Cladribine—Fatigue—Risedronate—osteoporosis	9.83e-05	0.000705	CcSEcCtD
Cladribine—Insomnia—Pamidronate—osteoporosis	9.8e-05	0.000703	CcSEcCtD
Cladribine—RRM2B—Metabolism—GAPDH—osteoporosis	9.79e-05	0.00151	CbGpPWpGaD
Cladribine—Pruritus—Ibandronate—osteoporosis	9.79e-05	0.000702	CcSEcCtD
Cladribine—Constipation—Risedronate—osteoporosis	9.75e-05	0.000699	CcSEcCtD
Cladribine—Pain—Risedronate—osteoporosis	9.75e-05	0.000699	CcSEcCtD
Cladribine—Angiopathy—Estradiol—osteoporosis	9.74e-05	0.000698	CcSEcCtD
Cladribine—Paraesthesia—Pamidronate—osteoporosis	9.73e-05	0.000698	CcSEcCtD
Cladribine—Diarrhoea—Alendronate—osteoporosis	9.72e-05	0.000697	CcSEcCtD
Cladribine—Asthenia—Calcitriol—osteoporosis	9.72e-05	0.000697	CcSEcCtD
Cladribine—Nervous system disorder—Zoledronate—osteoporosis	9.71e-05	0.000696	CcSEcCtD
Cladribine—Immune system disorder—Estradiol—osteoporosis	9.7e-05	0.000695	CcSEcCtD
Cladribine—Thrombocytopenia—Zoledronate—osteoporosis	9.69e-05	0.000695	CcSEcCtD
Cladribine—Mediastinal disorder—Estradiol—osteoporosis	9.68e-05	0.000694	CcSEcCtD
Cladribine—Dyspnoea—Pamidronate—osteoporosis	9.66e-05	0.000693	CcSEcCtD
Cladribine—Tachycardia—Zoledronate—osteoporosis	9.66e-05	0.000693	CcSEcCtD
Cladribine—RRM1—Metabolism—GPD2—osteoporosis	9.64e-05	0.00149	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PGLS—osteoporosis	9.64e-05	0.00149	CbGpPWpGaD
Cladribine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.64e-05	0.000691	CcSEcCtD
Cladribine—Chills—Estradiol—osteoporosis	9.64e-05	0.000691	CcSEcCtD
Cladribine—Somnolence—Pamidronate—osteoporosis	9.64e-05	0.000691	CcSEcCtD
Cladribine—Skin disorder—Zoledronate—osteoporosis	9.62e-05	0.000689	CcSEcCtD
Cladribine—Pruritus—Calcitriol—osteoporosis	9.58e-05	0.000687	CcSEcCtD
Cladribine—Hyperhidrosis—Zoledronate—osteoporosis	9.57e-05	0.000686	CcSEcCtD
Cladribine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.56e-05	0.000686	CcSEcCtD
Cladribine—Diarrhoea—Raloxifene—osteoporosis	9.56e-05	0.000685	CcSEcCtD
Cladribine—Dizziness—Estropipate—osteoporosis	9.54e-05	0.000684	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	9.54e-05	0.00147	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—RAP1A—osteoporosis	9.54e-05	0.00147	CbGpPWpGaD
Cladribine—Oedema—Conjugated Estrogens—osteoporosis	9.53e-05	0.000683	CcSEcCtD
Cladribine—Alopecia—Estradiol—osteoporosis	9.49e-05	0.00068	CcSEcCtD
Cladribine—Infection—Conjugated Estrogens—osteoporosis	9.47e-05	0.000679	CcSEcCtD
Cladribine—Diarrhoea—Ibandronate—osteoporosis	9.47e-05	0.000679	CcSEcCtD
Cladribine—Anorexia—Zoledronate—osteoporosis	9.44e-05	0.000677	CcSEcCtD
Cladribine—Decreased appetite—Pamidronate—osteoporosis	9.42e-05	0.000675	CcSEcCtD
Cladribine—Mental disorder—Estradiol—osteoporosis	9.41e-05	0.000674	CcSEcCtD
Cladribine—Dizziness—Alendronate—osteoporosis	9.4e-05	0.000674	CcSEcCtD
Cladribine—Gastrointestinal disorder—Pamidronate—osteoporosis	9.36e-05	0.000671	CcSEcCtD
Cladribine—Nervous system disorder—Conjugated Estrogens—osteoporosis	9.35e-05	0.00067	CcSEcCtD
Cladribine—Erythema—Estradiol—osteoporosis	9.35e-05	0.00067	CcSEcCtD
Cladribine—Malnutrition—Estradiol—osteoporosis	9.35e-05	0.00067	CcSEcCtD
Cladribine—Fatigue—Pamidronate—osteoporosis	9.35e-05	0.00067	CcSEcCtD
Cladribine—Gastrointestinal pain—Risedronate—osteoporosis	9.32e-05	0.000668	CcSEcCtD
Cladribine—Tachycardia—Conjugated Estrogens—osteoporosis	9.3e-05	0.000667	CcSEcCtD
Cladribine—Urticaria—Ethinyl Estradiol—osteoporosis	9.29e-05	0.000666	CcSEcCtD
Cladribine—POLE2—Mitotic G1-G1/S phases—MYC—osteoporosis	9.28e-05	0.00143	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—VDR—osteoporosis	9.27e-05	0.00143	CbGpPWpGaD
Cladribine—Pain—Pamidronate—osteoporosis	9.27e-05	0.000664	CcSEcCtD
Cladribine—Constipation—Pamidronate—osteoporosis	9.27e-05	0.000664	CcSEcCtD
Cladribine—Diarrhoea—Calcitriol—osteoporosis	9.27e-05	0.000664	CcSEcCtD
Cladribine—Skin disorder—Conjugated Estrogens—osteoporosis	9.26e-05	0.000664	CcSEcCtD
Cladribine—Hypotension—Zoledronate—osteoporosis	9.25e-05	0.000663	CcSEcCtD
Cladribine—Abdominal pain—Ethinyl Estradiol—osteoporosis	9.25e-05	0.000663	CcSEcCtD
Cladribine—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.25e-05	0.000663	CcSEcCtD
Cladribine—Dizziness—Raloxifene—osteoporosis	9.24e-05	0.000663	CcSEcCtD
Cladribine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.22e-05	0.000661	CcSEcCtD
Cladribine—Flatulence—Estradiol—osteoporosis	9.21e-05	0.00066	CcSEcCtD
Cladribine—PNP—Metabolism—TPI1—osteoporosis	9.2e-05	0.00142	CbGpPWpGaD
Cladribine—Vomiting—Estropipate—osteoporosis	9.17e-05	0.000658	CcSEcCtD
Cladribine—Dizziness—Ibandronate—osteoporosis	9.15e-05	0.000656	CcSEcCtD
Cladribine—Rash—Estropipate—osteoporosis	9.1e-05	0.000652	CcSEcCtD
Cladribine—Dermatitis—Estropipate—osteoporosis	9.09e-05	0.000652	CcSEcCtD
Cladribine—Anorexia—Conjugated Estrogens—osteoporosis	9.09e-05	0.000651	CcSEcCtD
Cladribine—Urticaria—Risedronate—osteoporosis	9.06e-05	0.000649	CcSEcCtD
Cladribine—Back pain—Estradiol—osteoporosis	9.04e-05	0.000648	CcSEcCtD
Cladribine—Headache—Estropipate—osteoporosis	9.04e-05	0.000648	CcSEcCtD
Cladribine—Vomiting—Alendronate—osteoporosis	9.04e-05	0.000648	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Zoledronate—osteoporosis	9.02e-05	0.000647	CcSEcCtD
Cladribine—Body temperature increased—Risedronate—osteoporosis	9.01e-05	0.000646	CcSEcCtD
Cladribine—Abdominal pain—Risedronate—osteoporosis	9.01e-05	0.000646	CcSEcCtD
Cladribine—Rash—Alendronate—osteoporosis	8.96e-05	0.000642	CcSEcCtD
Cladribine—Insomnia—Zoledronate—osteoporosis	8.96e-05	0.000642	CcSEcCtD
Cladribine—Dermatitis—Alendronate—osteoporosis	8.95e-05	0.000642	CcSEcCtD
Cladribine—Feeling abnormal—Pamidronate—osteoporosis	8.93e-05	0.00064	CcSEcCtD
Cladribine—Hypotension—Conjugated Estrogens—osteoporosis	8.91e-05	0.000639	CcSEcCtD
Cladribine—Headache—Alendronate—osteoporosis	8.9e-05	0.000638	CcSEcCtD
Cladribine—Paraesthesia—Zoledronate—osteoporosis	8.89e-05	0.000637	CcSEcCtD
Cladribine—Vomiting—Raloxifene—osteoporosis	8.89e-05	0.000637	CcSEcCtD
Cladribine—Gastrointestinal pain—Pamidronate—osteoporosis	8.86e-05	0.000635	CcSEcCtD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	8.86e-05	0.00137	CbGpPWpGaD
Cladribine—Dyspnoea—Zoledronate—osteoporosis	8.83e-05	0.000633	CcSEcCtD
Cladribine—RRM1—Metabolism—ATIC—osteoporosis	8.82e-05	0.00136	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PNP—osteoporosis	8.82e-05	0.00136	CbGpPWpGaD
Cladribine—Rash—Raloxifene—osteoporosis	8.81e-05	0.000632	CcSEcCtD
Cladribine—Dermatitis—Raloxifene—osteoporosis	8.8e-05	0.000631	CcSEcCtD
Cladribine—Somnolence—Zoledronate—osteoporosis	8.8e-05	0.000631	CcSEcCtD
Cladribine—Vomiting—Ibandronate—osteoporosis	8.8e-05	0.000631	CcSEcCtD
Cladribine—Headache—Raloxifene—osteoporosis	8.76e-05	0.000628	CcSEcCtD
Cladribine—Rash—Ibandronate—osteoporosis	8.72e-05	0.000625	CcSEcCtD
Cladribine—Dermatitis—Ibandronate—osteoporosis	8.72e-05	0.000625	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.69e-05	0.000623	CcSEcCtD
Cladribine—Ill-defined disorder—Estradiol—osteoporosis	8.67e-05	0.000622	CcSEcCtD
Cladribine—Headache—Ibandronate—osteoporosis	8.67e-05	0.000621	CcSEcCtD
Cladribine—PNP—Metabolism—P4HB—osteoporosis	8.65e-05	0.00133	CbGpPWpGaD
Cladribine—Insomnia—Conjugated Estrogens—osteoporosis	8.62e-05	0.000618	CcSEcCtD
Cladribine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.62e-05	0.000618	CcSEcCtD
Cladribine—Vomiting—Calcitriol—osteoporosis	8.61e-05	0.000617	CcSEcCtD
Cladribine—Decreased appetite—Zoledronate—osteoporosis	8.61e-05	0.000617	CcSEcCtD
Cladribine—Nausea—Estropipate—osteoporosis	8.57e-05	0.000614	CcSEcCtD
Cladribine—Abdominal pain—Pamidronate—osteoporosis	8.57e-05	0.000614	CcSEcCtD
Cladribine—Body temperature increased—Pamidronate—osteoporosis	8.57e-05	0.000614	CcSEcCtD
Cladribine—Paraesthesia—Conjugated Estrogens—osteoporosis	8.56e-05	0.000614	CcSEcCtD
Cladribine—Gastrointestinal disorder—Zoledronate—osteoporosis	8.55e-05	0.000613	CcSEcCtD
Cladribine—Rash—Calcitriol—osteoporosis	8.54e-05	0.000612	CcSEcCtD
Cladribine—Fatigue—Zoledronate—osteoporosis	8.54e-05	0.000612	CcSEcCtD
Cladribine—Dermatitis—Calcitriol—osteoporosis	8.53e-05	0.000612	CcSEcCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	8.5e-05	0.00131	CbGpPWpGaD
Cladribine—Dyspnoea—Conjugated Estrogens—osteoporosis	8.5e-05	0.000609	CcSEcCtD
Cladribine—PNP—Metabolism—GAPDH—osteoporosis	8.49e-05	0.00131	CbGpPWpGaD
Cladribine—Headache—Calcitriol—osteoporosis	8.49e-05	0.000608	CcSEcCtD
Cladribine—Somnolence—Conjugated Estrogens—osteoporosis	8.48e-05	0.000608	CcSEcCtD
Cladribine—Pain—Zoledronate—osteoporosis	8.47e-05	0.000607	CcSEcCtD
Cladribine—Constipation—Zoledronate—osteoporosis	8.47e-05	0.000607	CcSEcCtD
Cladribine—Nausea—Alendronate—osteoporosis	8.44e-05	0.000605	CcSEcCtD
Cladribine—Malaise—Estradiol—osteoporosis	8.43e-05	0.000604	CcSEcCtD
Cladribine—Hypersensitivity—Risedronate—osteoporosis	8.4e-05	0.000602	CcSEcCtD
Cladribine—Asthenia—Ethinyl Estradiol—osteoporosis	8.39e-05	0.000602	CcSEcCtD
Cladribine—RRM2—Metabolism—PKM—osteoporosis	8.38e-05	0.00129	CbGpPWpGaD
Cladribine—RRM2—Metabolism—FDPS—osteoporosis	8.38e-05	0.00129	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—LEP—osteoporosis	8.32e-05	0.00128	CbGpPWpGaD
Cladribine—Nausea—Raloxifene—osteoporosis	8.3e-05	0.000595	CcSEcCtD
Cladribine—Decreased appetite—Conjugated Estrogens—osteoporosis	8.29e-05	0.000594	CcSEcCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	8.28e-05	0.00128	CbGpPWpGaD
Cladribine—Pruritus—Ethinyl Estradiol—osteoporosis	8.27e-05	0.000593	CcSEcCtD
Cladribine—PNP—Metabolism—RAP1A—osteoporosis	8.27e-05	0.00127	CbGpPWpGaD
Cladribine—PNP—Levonorgestrel—Ethinyl Estradiol—osteoporosis	8.24e-05	0.0248	CbGdCrCtD
Cladribine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.23e-05	0.00059	CcSEcCtD
Cladribine—Fatigue—Conjugated Estrogens—osteoporosis	8.22e-05	0.000589	CcSEcCtD
Cladribine—Nausea—Ibandronate—osteoporosis	8.22e-05	0.000589	CcSEcCtD
Cladribine—Asthenia—Risedronate—osteoporosis	8.18e-05	0.000586	CcSEcCtD
Cladribine—Feeling abnormal—Zoledronate—osteoporosis	8.16e-05	0.000585	CcSEcCtD
Cladribine—Cough—Estradiol—osteoporosis	8.16e-05	0.000585	CcSEcCtD
Cladribine—Pain—Conjugated Estrogens—osteoporosis	8.15e-05	0.000584	CcSEcCtD
Cladribine—Constipation—Conjugated Estrogens—osteoporosis	8.15e-05	0.000584	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—PSMA5—osteoporosis	8.11e-05	0.00125	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—PSMA2—osteoporosis	8.11e-05	0.00125	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Zoledronate—osteoporosis	8.1e-05	0.00058	CcSEcCtD
Cladribine—Pruritus—Risedronate—osteoporosis	8.07e-05	0.000578	CcSEcCtD
Cladribine—Nausea—Calcitriol—osteoporosis	8.05e-05	0.000577	CcSEcCtD
Cladribine—Diarrhoea—Ethinyl Estradiol—osteoporosis	8e-05	0.000574	CcSEcCtD
Cladribine—Hypersensitivity—Pamidronate—osteoporosis	7.99e-05	0.000572	CcSEcCtD
Cladribine—Myalgia—Estradiol—osteoporosis	7.96e-05	0.000571	CcSEcCtD
Cladribine—Arthralgia—Estradiol—osteoporosis	7.96e-05	0.000571	CcSEcCtD
Cladribine—Chest pain—Estradiol—osteoporosis	7.96e-05	0.000571	CcSEcCtD
Cladribine—RRM2—Metabolism—PGLS—osteoporosis	7.94e-05	0.00122	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GPD2—osteoporosis	7.94e-05	0.00122	CbGpPWpGaD
Cladribine—Anxiety—Estradiol—osteoporosis	7.93e-05	0.000569	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.9e-05	0.000567	CcSEcCtD
Cladribine—Urticaria—Zoledronate—osteoporosis	7.87e-05	0.000564	CcSEcCtD
Cladribine—Discomfort—Estradiol—osteoporosis	7.86e-05	0.000564	CcSEcCtD
Cladribine—DCK—Metabolism—FDPS—osteoporosis	7.83e-05	0.00121	CbGpPWpGaD
Cladribine—DCK—Metabolism—PKM—osteoporosis	7.83e-05	0.00121	CbGpPWpGaD
Cladribine—Abdominal pain—Zoledronate—osteoporosis	7.83e-05	0.000561	CcSEcCtD
Cladribine—Body temperature increased—Zoledronate—osteoporosis	7.83e-05	0.000561	CcSEcCtD
Cladribine—Diarrhoea—Risedronate—osteoporosis	7.8e-05	0.000559	CcSEcCtD
Cladribine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.8e-05	0.000559	CcSEcCtD
Cladribine—POLE—Cell Cycle, Mitotic—PSMA5—osteoporosis	7.78e-05	0.0012	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—PSMA2—osteoporosis	7.78e-05	0.0012	CbGpPWpGaD
Cladribine—Asthenia—Pamidronate—osteoporosis	7.78e-05	0.000557	CcSEcCtD
Cladribine—Dizziness—Ethinyl Estradiol—osteoporosis	7.73e-05	0.000554	CcSEcCtD
Cladribine—RRM2B—Metabolism—ENO1—osteoporosis	7.71e-05	0.00119	CbGpPWpGaD
Cladribine—Confusional state—Estradiol—osteoporosis	7.69e-05	0.000552	CcSEcCtD
Cladribine—Pruritus—Pamidronate—osteoporosis	7.67e-05	0.00055	CcSEcCtD
Cladribine—Oedema—Estradiol—osteoporosis	7.63e-05	0.000547	CcSEcCtD
Cladribine—RRM2B—Metabolism—PSMA5—osteoporosis	7.6e-05	0.00117	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PSMA2—osteoporosis	7.6e-05	0.00117	CbGpPWpGaD
Cladribine—Infection—Estradiol—osteoporosis	7.58e-05	0.000543	CcSEcCtD
Cladribine—Urticaria—Conjugated Estrogens—osteoporosis	7.57e-05	0.000543	CcSEcCtD
Cladribine—Dizziness—Risedronate—osteoporosis	7.54e-05	0.000541	CcSEcCtD
Cladribine—Abdominal pain—Conjugated Estrogens—osteoporosis	7.54e-05	0.00054	CcSEcCtD
Cladribine—Body temperature increased—Conjugated Estrogens—osteoporosis	7.54e-05	0.00054	CcSEcCtD
Cladribine—RRM1—Metabolism—CA2—osteoporosis	7.5e-05	0.00116	CbGpPWpGaD
Cladribine—RRM1—Metabolism—OXCT1—osteoporosis	7.5e-05	0.00116	CbGpPWpGaD
Cladribine—Nervous system disorder—Estradiol—osteoporosis	7.48e-05	0.000536	CcSEcCtD
Cladribine—Tachycardia—Estradiol—osteoporosis	7.45e-05	0.000534	CcSEcCtD
Cladribine—Vomiting—Ethinyl Estradiol—osteoporosis	7.44e-05	0.000533	CcSEcCtD
Cladribine—DCK—Metabolism—PGLS—osteoporosis	7.42e-05	0.00114	CbGpPWpGaD
Cladribine—DCK—Metabolism—GPD2—osteoporosis	7.42e-05	0.00114	CbGpPWpGaD
Cladribine—Diarrhoea—Pamidronate—osteoporosis	7.42e-05	0.000532	CcSEcCtD
Cladribine—POLA1—Mitotic M-M/G1 phases—PSMA2—osteoporosis	7.42e-05	0.00114	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—PSMA5—osteoporosis	7.42e-05	0.00114	CbGpPWpGaD
Cladribine—Skin disorder—Estradiol—osteoporosis	7.41e-05	0.000531	CcSEcCtD
Cladribine—RRM2—G1/S Transition—MYC—osteoporosis	7.4e-05	0.00114	CbGpPWpGaD
Cladribine—Hyperhidrosis—Estradiol—osteoporosis	7.38e-05	0.000529	CcSEcCtD
Cladribine—Rash—Ethinyl Estradiol—osteoporosis	7.37e-05	0.000529	CcSEcCtD
Cladribine—Dermatitis—Ethinyl Estradiol—osteoporosis	7.37e-05	0.000528	CcSEcCtD
Cladribine—Headache—Ethinyl Estradiol—osteoporosis	7.33e-05	0.000525	CcSEcCtD
Cladribine—RRM1—Metabolism—MGLL—osteoporosis	7.31e-05	0.00113	CbGpPWpGaD
Cladribine—Hypersensitivity—Zoledronate—osteoporosis	7.29e-05	0.000523	CcSEcCtD
Cladribine—RRM2—Metabolism—PNP—osteoporosis	7.26e-05	0.00112	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ATIC—osteoporosis	7.26e-05	0.00112	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—PSMA5—osteoporosis	7.25e-05	0.00112	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—PSMA2—osteoporosis	7.25e-05	0.00112	CbGpPWpGaD
Cladribine—Vomiting—Risedronate—osteoporosis	7.25e-05	0.00052	CcSEcCtD
Cladribine—Rash—Risedronate—osteoporosis	7.19e-05	0.000515	CcSEcCtD
Cladribine—Dermatitis—Risedronate—osteoporosis	7.18e-05	0.000515	CcSEcCtD
Cladribine—Dizziness—Pamidronate—osteoporosis	7.17e-05	0.000514	CcSEcCtD
Cladribine—Headache—Risedronate—osteoporosis	7.14e-05	0.000512	CcSEcCtD
Cladribine—Asthenia—Zoledronate—osteoporosis	7.1e-05	0.000509	CcSEcCtD
Cladribine—POLE—G1/S Transition—MYC—osteoporosis	7.1e-05	0.00109	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—ESR1—osteoporosis	7.09e-05	0.00109	CbGpPWpGaD
Cladribine—Hypersensitivity—Conjugated Estrogens—osteoporosis	7.02e-05	0.000504	CcSEcCtD
Cladribine—Pruritus—Zoledronate—osteoporosis	7.01e-05	0.000502	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—LEP—osteoporosis	6.99e-05	0.00108	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—MYC—osteoporosis	6.97e-05	0.00107	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—PSMA5—osteoporosis	6.96e-05	0.00107	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—PSMA2—osteoporosis	6.96e-05	0.00107	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Estradiol—osteoporosis	6.95e-05	0.000498	CcSEcCtD
Cladribine—Nausea—Ethinyl Estradiol—osteoporosis	6.95e-05	0.000498	CcSEcCtD
Cladribine—Insomnia—Estradiol—osteoporosis	6.9e-05	0.000495	CcSEcCtD
Cladribine—Vomiting—Pamidronate—osteoporosis	6.89e-05	0.000494	CcSEcCtD
Cladribine—Paraesthesia—Estradiol—osteoporosis	6.85e-05	0.000491	CcSEcCtD
Cladribine—Asthenia—Conjugated Estrogens—osteoporosis	6.84e-05	0.00049	CcSEcCtD
Cladribine—Rash—Pamidronate—osteoporosis	6.83e-05	0.00049	CcSEcCtD
Cladribine—Dermatitis—Pamidronate—osteoporosis	6.83e-05	0.000489	CcSEcCtD
Cladribine—Dyspnoea—Estradiol—osteoporosis	6.8e-05	0.000488	CcSEcCtD
Cladribine—Headache—Pamidronate—osteoporosis	6.79e-05	0.000487	CcSEcCtD
Cladribine—DCK—Metabolism—PNP—osteoporosis	6.79e-05	0.00105	CbGpPWpGaD
Cladribine—DCK—Metabolism—ATIC—osteoporosis	6.79e-05	0.00105	CbGpPWpGaD
Cladribine—Somnolence—Estradiol—osteoporosis	6.78e-05	0.000486	CcSEcCtD
Cladribine—Diarrhoea—Zoledronate—osteoporosis	6.77e-05	0.000486	CcSEcCtD
Cladribine—Nausea—Risedronate—osteoporosis	6.77e-05	0.000486	CcSEcCtD
Cladribine—Pruritus—Conjugated Estrogens—osteoporosis	6.75e-05	0.000484	CcSEcCtD
Cladribine—PNP—Metabolism—ENO1—osteoporosis	6.68e-05	0.00103	CbGpPWpGaD
Cladribine—Decreased appetite—Estradiol—osteoporosis	6.63e-05	0.000475	CcSEcCtD
Cladribine—Gastrointestinal disorder—Estradiol—osteoporosis	6.59e-05	0.000472	CcSEcCtD
Cladribine—PNP—Metabolism—PSMA5—osteoporosis	6.59e-05	0.00102	CbGpPWpGaD
Cladribine—PNP—Metabolism—PSMA2—osteoporosis	6.59e-05	0.00102	CbGpPWpGaD
Cladribine—Fatigue—Estradiol—osteoporosis	6.58e-05	0.000472	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.57e-05	0.00101	CbGpPWpGaD
Cladribine—Dizziness—Zoledronate—osteoporosis	6.55e-05	0.000469	CcSEcCtD
Cladribine—Pain—Estradiol—osteoporosis	6.52e-05	0.000468	CcSEcCtD
Cladribine—Constipation—Estradiol—osteoporosis	6.52e-05	0.000468	CcSEcCtD
Cladribine—Diarrhoea—Conjugated Estrogens—osteoporosis	6.52e-05	0.000468	CcSEcCtD
Cladribine—POLE—S Phase—MYC—osteoporosis	6.45e-05	0.000993	CbGpPWpGaD
Cladribine—Nausea—Pamidronate—osteoporosis	6.44e-05	0.000462	CcSEcCtD
Cladribine—Dizziness—Conjugated Estrogens—osteoporosis	6.3e-05	0.000452	CcSEcCtD
Cladribine—NR5A1—Gene Expression—PSMA5—osteoporosis	6.3e-05	0.00097	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—PSMA2—osteoporosis	6.3e-05	0.00097	CbGpPWpGaD
Cladribine—Vomiting—Zoledronate—osteoporosis	6.3e-05	0.000451	CcSEcCtD
Cladribine—Feeling abnormal—Estradiol—osteoporosis	6.29e-05	0.000451	CcSEcCtD
Cladribine—Rash—Zoledronate—osteoporosis	6.24e-05	0.000448	CcSEcCtD
Cladribine—Gastrointestinal pain—Estradiol—osteoporosis	6.24e-05	0.000447	CcSEcCtD
Cladribine—Dermatitis—Zoledronate—osteoporosis	6.24e-05	0.000447	CcSEcCtD
Cladribine—RRM2—Mitotic G1-G1/S phases—MYC—osteoporosis	6.23e-05	0.000961	CbGpPWpGaD
Cladribine—RRM1—Metabolism—IDH2—osteoporosis	6.21e-05	0.000958	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.21e-05	0.000957	CbGpPWpGaD
Cladribine—Headache—Zoledronate—osteoporosis	6.2e-05	0.000445	CcSEcCtD
Cladribine—RRM2—Metabolism—OXCT1—osteoporosis	6.18e-05	0.000952	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CA2—osteoporosis	6.18e-05	0.000952	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP19A1—osteoporosis	6.16e-05	0.00095	CbGpPWpGaD
Cladribine—Vomiting—Conjugated Estrogens—osteoporosis	6.06e-05	0.000435	CcSEcCtD
Cladribine—Urticaria—Estradiol—osteoporosis	6.06e-05	0.000435	CcSEcCtD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	6.06e-05	0.000934	CbGpPWpGaD
Cladribine—Abdominal pain—Estradiol—osteoporosis	6.03e-05	0.000432	CcSEcCtD
Cladribine—Body temperature increased—Estradiol—osteoporosis	6.03e-05	0.000432	CcSEcCtD
Cladribine—RRM2—Metabolism—MGLL—osteoporosis	6.02e-05	0.000928	CbGpPWpGaD
Cladribine—Rash—Conjugated Estrogens—osteoporosis	6.01e-05	0.000431	CcSEcCtD
Cladribine—Dermatitis—Conjugated Estrogens—osteoporosis	6.01e-05	0.000431	CcSEcCtD
Cladribine—POLE—Mitotic G1-G1/S phases—MYC—osteoporosis	5.98e-05	0.000922	CbGpPWpGaD
Cladribine—Headache—Conjugated Estrogens—osteoporosis	5.97e-05	0.000428	CcSEcCtD
Cladribine—Nausea—Zoledronate—osteoporosis	5.88e-05	0.000422	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—IL6R—osteoporosis	5.85e-05	0.000902	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP27A1—osteoporosis	5.84e-05	0.000901	CbGpPWpGaD
Cladribine—DCK—Metabolism—OXCT1—osteoporosis	5.77e-05	0.00089	CbGpPWpGaD
Cladribine—DCK—Metabolism—CA2—osteoporosis	5.77e-05	0.00089	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	5.73e-05	0.000884	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	5.72e-05	0.000882	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ACP5—osteoporosis	5.68e-05	0.000876	CbGpPWpGaD
Cladribine—Nausea—Conjugated Estrogens—osteoporosis	5.66e-05	0.000406	CcSEcCtD
Cladribine—NR5A1—Gene Expression—ESR2—osteoporosis	5.63e-05	0.000867	CbGpPWpGaD
Cladribine—DCK—Metabolism—MGLL—osteoporosis	5.62e-05	0.000867	CbGpPWpGaD
Cladribine—Hypersensitivity—Estradiol—osteoporosis	5.62e-05	0.000403	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—PSMA2—osteoporosis	5.55e-05	0.000855	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—PSMA5—osteoporosis	5.55e-05	0.000855	CbGpPWpGaD
Cladribine—Asthenia—Estradiol—osteoporosis	5.47e-05	0.000392	CcSEcCtD
Cladribine—Pruritus—Estradiol—osteoporosis	5.4e-05	0.000387	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.37e-05	0.000828	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP19A1—osteoporosis	5.34e-05	0.000824	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	5.34e-05	0.000823	CbGpPWpGaD
Cladribine—RRM1—Metabolism—TPI1—osteoporosis	5.28e-05	0.000814	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	5.24e-05	0.000808	CbGpPWpGaD
Cladribine—Diarrhoea—Estradiol—osteoporosis	5.22e-05	0.000374	CcSEcCtD
Cladribine—RRM2—Metabolism—IDH2—osteoporosis	5.12e-05	0.000789	CbGpPWpGaD
Cladribine—POLA1—G1/S Transition—MYC—osteoporosis	5.06e-05	0.00078	CbGpPWpGaD
Cladribine—Dizziness—Estradiol—osteoporosis	5.05e-05	0.000362	CcSEcCtD
Cladribine—RRM2B—Metabolism—ADCY5—osteoporosis	5.04e-05	0.000776	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—GPX1—osteoporosis	5.02e-05	0.000774	CbGpPWpGaD
Cladribine—RRM1—Metabolism—P4HB—osteoporosis	4.97e-05	0.000766	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—PSMA2—osteoporosis	4.96e-05	0.000765	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—PSMA5—osteoporosis	4.96e-05	0.000765	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GAPDH—osteoporosis	4.88e-05	0.000752	CbGpPWpGaD
Cladribine—Vomiting—Estradiol—osteoporosis	4.85e-05	0.000348	CcSEcCtD
Cladribine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	4.81e-05	0.0145	CbGdCrCtD
Cladribine—RRM2—Metabolism—CYP27A1—osteoporosis	4.81e-05	0.000742	CbGpPWpGaD
Cladribine—Rash—Estradiol—osteoporosis	4.81e-05	0.000345	CcSEcCtD
Cladribine—Dermatitis—Estradiol—osteoporosis	4.81e-05	0.000345	CcSEcCtD
Cladribine—DCK—Metabolism—IDH2—osteoporosis	4.78e-05	0.000737	CbGpPWpGaD
Cladribine—Headache—Estradiol—osteoporosis	4.78e-05	0.000343	CcSEcCtD
Cladribine—RRM1—Metabolism—RAP1A—osteoporosis	4.75e-05	0.000732	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ACP5—osteoporosis	4.68e-05	0.000721	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—MTHFR—osteoporosis	4.63e-05	0.000714	CbGpPWpGaD
Cladribine—POLA1—S Phase—MYC—osteoporosis	4.59e-05	0.000708	CbGpPWpGaD
Cladribine—Nausea—Estradiol—osteoporosis	4.53e-05	0.000325	CcSEcCtD
Cladribine—DCK—Metabolism—CYP27A1—osteoporosis	4.5e-05	0.000693	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—VDR—osteoporosis	4.46e-05	0.000688	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.4e-05	0.000677	CbGpPWpGaD
Cladribine—DCK—Metabolism—ACP5—osteoporosis	4.37e-05	0.000674	CbGpPWpGaD
Cladribine—PNP—Metabolism—ADCY5—osteoporosis	4.37e-05	0.000673	CbGpPWpGaD
Cladribine—RRM2—Metabolism—TPI1—osteoporosis	4.35e-05	0.000671	CbGpPWpGaD
Cladribine—PNP—Metabolism—GPX1—osteoporosis	4.35e-05	0.000671	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.35e-05	0.00067	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—MYC—osteoporosis	4.26e-05	0.000657	CbGpPWpGaD
Cladribine—RRM2—Metabolism—P4HB—osteoporosis	4.09e-05	0.000631	CbGpPWpGaD
Cladribine—DCK—Metabolism—TPI1—osteoporosis	4.07e-05	0.000627	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.05e-05	0.000625	CbGpPWpGaD
Cladribine—PNP—Metabolism—MTHFR—osteoporosis	4.02e-05	0.000619	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GAPDH—osteoporosis	4.02e-05	0.000619	CbGpPWpGaD
Cladribine—SLC22A2—Transmission across Chemical Synapses—ADCY5—osteoporosis	3.96e-05	0.000611	CbGpPWpGaD
Cladribine—RRM2—Metabolism—RAP1A—osteoporosis	3.91e-05	0.000603	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ENO1—osteoporosis	3.84e-05	0.000592	CbGpPWpGaD
Cladribine—DCK—Metabolism—P4HB—osteoporosis	3.82e-05	0.000589	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PSMA5—osteoporosis	3.78e-05	0.000583	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PSMA2—osteoporosis	3.78e-05	0.000583	CbGpPWpGaD
Cladribine—DCK—Metabolism—GAPDH—osteoporosis	3.75e-05	0.000578	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—POMC—osteoporosis	3.7e-05	0.000571	CbGpPWpGaD
Cladribine—SLC22A1—Transmission across Chemical Synapses—ADCY5—osteoporosis	3.69e-05	0.000569	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—MYC—osteoporosis	3.69e-05	0.000568	CbGpPWpGaD
Cladribine—DCK—Metabolism—RAP1A—osteoporosis	3.65e-05	0.000563	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TGFB1—osteoporosis	3.46e-05	0.000533	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—ESR1—osteoporosis	3.41e-05	0.000526	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—MYC—osteoporosis	3.41e-05	0.000525	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—osteoporosis	3.23e-05	0.000498	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.23e-05	0.000498	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.22e-05	0.000497	CbGpPWpGaD
Cladribine—PNP—Metabolism—POMC—osteoporosis	3.21e-05	0.000495	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ENO1—osteoporosis	3.16e-05	0.000487	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—FDPS—osteoporosis	3.13e-05	0.000483	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PKM—osteoporosis	3.13e-05	0.000483	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PSMA5—osteoporosis	3.12e-05	0.00048	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PSMA2—osteoporosis	3.12e-05	0.00048	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—FDPS—osteoporosis	3.1e-05	0.000478	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PKM—osteoporosis	3.1e-05	0.000478	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP19A1—osteoporosis	3.07e-05	0.000473	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—MYC—osteoporosis	3.04e-05	0.000469	CbGpPWpGaD
Cladribine—SLC22A2—Neuronal System—ADCY5—osteoporosis	3.04e-05	0.000468	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.01e-05	0.000464	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPD2—osteoporosis	2.97e-05	0.000458	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PGLS—osteoporosis	2.97e-05	0.000458	CbGpPWpGaD
Cladribine—DCK—Metabolism—ENO1—osteoporosis	2.95e-05	0.000455	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PGLS—osteoporosis	2.94e-05	0.000453	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPD2—osteoporosis	2.94e-05	0.000453	CbGpPWpGaD
Cladribine—DCK—Metabolism—PSMA2—osteoporosis	2.91e-05	0.000449	CbGpPWpGaD
Cladribine—DCK—Metabolism—PSMA5—osteoporosis	2.91e-05	0.000449	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PKM—osteoporosis	2.89e-05	0.000445	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—FDPS—osteoporosis	2.89e-05	0.000445	CbGpPWpGaD
Cladribine—SLC22A1—Neuronal System—ADCY5—osteoporosis	2.83e-05	0.000436	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PGLS—osteoporosis	2.74e-05	0.000422	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPD2—osteoporosis	2.74e-05	0.000422	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ATIC—osteoporosis	2.72e-05	0.000419	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PNP—osteoporosis	2.72e-05	0.000419	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PNP—osteoporosis	2.69e-05	0.000414	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ATIC—osteoporosis	2.69e-05	0.000414	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—osteoporosis	2.61e-05	0.000402	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP19A1—osteoporosis	2.53e-05	0.00039	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ADCY5—osteoporosis	2.51e-05	0.000387	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ATIC—osteoporosis	2.51e-05	0.000386	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PNP—osteoporosis	2.51e-05	0.000386	CbGpPWpGaD
Cladribine—RRM1—Metabolism—GPX1—osteoporosis	2.5e-05	0.000385	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP19A1—osteoporosis	2.36e-05	0.000364	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—OXCT1—osteoporosis	2.31e-05	0.000356	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CA2—osteoporosis	2.31e-05	0.000356	CbGpPWpGaD
Cladribine—RRM1—Metabolism—MTHFR—osteoporosis	2.31e-05	0.000356	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CA2—osteoporosis	2.29e-05	0.000352	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—OXCT1—osteoporosis	2.29e-05	0.000352	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—MYC—osteoporosis	2.29e-05	0.000352	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MGLL—osteoporosis	2.25e-05	0.000347	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MGLL—osteoporosis	2.23e-05	0.000343	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—MYC—osteoporosis	2.19e-05	0.000338	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—OXCT1—osteoporosis	2.13e-05	0.000328	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CA2—osteoporosis	2.13e-05	0.000328	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MGLL—osteoporosis	2.08e-05	0.00032	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000318	CbGpPWpGaD
Cladribine—RRM2—Metabolism—GPX1—osteoporosis	2.06e-05	0.000317	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—MYC—osteoporosis	2.04e-05	0.000315	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—MYC—osteoporosis	1.96e-05	0.000302	CbGpPWpGaD
Cladribine—DCK—Metabolism—ADCY5—osteoporosis	1.93e-05	0.000297	CbGpPWpGaD
Cladribine—DCK—Metabolism—GPX1—osteoporosis	1.92e-05	0.000296	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—IDH2—osteoporosis	1.91e-05	0.000295	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—osteoporosis	1.9e-05	0.000293	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—IDH2—osteoporosis	1.89e-05	0.000292	CbGpPWpGaD
Cladribine—RRM1—Metabolism—POMC—osteoporosis	1.84e-05	0.000284	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP27A1—osteoporosis	1.8e-05	0.000277	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP27A1—osteoporosis	1.78e-05	0.000274	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—osteoporosis	1.77e-05	0.000274	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MYC—osteoporosis	1.77e-05	0.000274	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—IDH2—osteoporosis	1.77e-05	0.000272	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ACP5—osteoporosis	1.75e-05	0.00027	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ACP5—osteoporosis	1.73e-05	0.000267	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP27A1—osteoporosis	1.66e-05	0.000256	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.65e-05	0.000254	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.63e-05	0.000252	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—TPI1—osteoporosis	1.63e-05	0.000251	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ACP5—osteoporosis	1.61e-05	0.000249	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—TPI1—osteoporosis	1.61e-05	0.000248	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—MYC—osteoporosis	1.56e-05	0.000241	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—P4HB—osteoporosis	1.53e-05	0.000236	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.52e-05	0.000234	CbGpPWpGaD
Cladribine—RRM2—Metabolism—POMC—osteoporosis	1.52e-05	0.000234	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—P4HB—osteoporosis	1.51e-05	0.000233	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GAPDH—osteoporosis	1.5e-05	0.000231	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—TPI1—osteoporosis	1.5e-05	0.000231	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GAPDH—osteoporosis	1.49e-05	0.000229	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RAP1A—osteoporosis	1.46e-05	0.000225	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RAP1A—osteoporosis	1.45e-05	0.000223	CbGpPWpGaD
Cladribine—DCK—Metabolism—POMC—osteoporosis	1.42e-05	0.000219	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—P4HB—osteoporosis	1.41e-05	0.000218	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—MYC—osteoporosis	1.4e-05	0.000215	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GAPDH—osteoporosis	1.39e-05	0.000214	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RAP1A—osteoporosis	1.35e-05	0.000208	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ENO1—osteoporosis	1.18e-05	0.000182	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ENO1—osteoporosis	1.17e-05	0.00018	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PSMA5—osteoporosis	1.17e-05	0.00018	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PSMA2—osteoporosis	1.17e-05	0.00018	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PSMA5—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PSMA2—osteoporosis	1.15e-05	0.000178	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ENO1—osteoporosis	1.09e-05	0.000168	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PSMA2—osteoporosis	1.07e-05	0.000166	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PSMA5—osteoporosis	1.07e-05	0.000166	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP19A1—osteoporosis	9.45e-06	0.000146	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP19A1—osteoporosis	9.35e-06	0.000144	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP19A1—osteoporosis	8.72e-06	0.000134	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADCY5—osteoporosis	7.72e-06	0.000119	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPX1—osteoporosis	7.7e-06	0.000119	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADCY5—osteoporosis	7.64e-06	0.000118	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPX1—osteoporosis	7.62e-06	0.000117	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADCY5—osteoporosis	7.12e-06	0.00011	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—osteoporosis	7.1e-06	0.000109	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPX1—osteoporosis	7.1e-06	0.000109	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—osteoporosis	7.03e-06	0.000108	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—osteoporosis	6.55e-06	0.000101	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—POMC—osteoporosis	5.68e-06	8.76e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—POMC—osteoporosis	5.62e-06	8.67e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—POMC—osteoporosis	5.24e-06	8.08e-05	CbGpPWpGaD
